Endocrine function assessment is a systematic laboratory evaluation of hormone synthesis, secretion, regulation, and feedback control across the hypothalamic–pituitary–target gland axes. This technical guide explains the specimen types, hormone test panels, analytical methods, and quality frameworks—such as ISO 15189 and ISO/IEC 17025—that support accurate and reliable endocrine testing in accredited third-party laboratories and clinical diagnostic settings.
Technical Overview
The endocrine system comprises glands such as the hypothalamus, pituitary, thyroid, parathyroids, adrenal glands, gonads, and pancreatic islets, which release hormones directly into the bloodstream to regulate metabolism, growth, reproduction, electrolyte balance, and stress responses. Endocrine function assessment measures hormone concentrations and evaluates the integrity of feedback loops to identify hyperfunction, hypofunction, or hormone-resistance syndromes.
A complete evaluation integrates three layers of evidence: basal hormone levels, dynamic stimulation or suppression testing when basal results are inconclusive, and adjunct markers such as binding proteins, autoantibodies, and metabolites. Because many hormones follow circadian, ultradian, or menstrual-cycle-dependent secretion patterns, standardized sample collection timing is critical for interpretable results. Accredited third-party laboratories and medical laboratories operating under ISO 15189 quality management systems apply validated methods, traceable calibrators, and age- and sex-specific reference intervals to ensure analytical accuracy and clinical relevance.
Testing Samples
Serum and Plasma
Venous blood collected into serum separator, EDTA, or heparin tubes is the primary matrix for most hormone assays, including thyroid hormones, reproductive steroids, pituitary hormones, and insulin. Samples are typically collected in the morning after an overnight fast to minimize diurnal and dietary variation, and centrifuged promptly to separate cells from the analyte-containing fluid.
24-Hour Urine
A complete 24-hour urine collection is used to quantify cumulative hormone and metabolite excretion, particularly free cortisol, catecholamines, and fractionated metanephrines. Urine sampling averages out pulsatile secretion and provides complementary information to single-time-point blood measurements.
Saliva
Salivary sampling offers a noninvasive option for hormones that pass freely into saliva, such as late-night salivary cortisol for Cushing syndrome screening and melatonin for circadian rhythm studies. Collection at defined clock times is essential for interpretation.
Dried Blood Spots and Other Specimens
Capillary dried blood spots are widely used in newborn screening programs for thyroid-stimulating hormone and 17-hydroxyprogesterone. Specialized assessments may also use cerebrospinal fluid or tissue specimens under strict chain-of-custody and pre-analytical controls.
Testing Items
Endocrine function assessment is organized into organ-specific panels that can be combined or customized according to clinical suspicion:
- Thyroid function panel: TSH, free T3, free T4, total T3, total T4, thyroid peroxidase antibodies, thyroglobulin antibodies, TSH receptor antibodies, thyroglobulin
- Adrenal function panel: cortisol, adrenocorticotropic hormone (ACTH), aldosterone, renin activity or direct renin concentration, dehydroepiandrosterone sulfate (DHEA-S), 17-hydroxyprogesterone, plasma free metanephrines, urine catecholamines
- Reproductive hormone panel: luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, progesterone, total and free testosterone, prolactin, sex hormone-binding globulin (SHBG), anti-Müllerian hormone (AMH), human chorionic gonadotropin (hCG)
- Pituitary and growth axis: growth hormone (GH), insulin-like growth factor 1 (IGF-1), insulin-like growth factor binding protein 3 (IGFBP-3), antidiuretic hormone (ADH), oxytocin
- Glucose and metabolic hormones: fasting insulin, C-peptide, proinsulin, hemoglobin A1c, fasting glucose, glucagon, incretins
- Bone and mineral metabolism: parathyroid hormone (PTH), ionized calcium, phosphorus, 25-hydroxy vitamin D, 1,25-dihydroxy vitamin D, calcitonin, magnesium
Testing Methods
Immunoassay Platforms
Chemiluminescent immunoassay (CLIA), electrochemiluminescent immunoassay (ECLIA), and enzyme-linked immunosorbent assay (ELISA) are the workhorses of endocrine testing, offering high throughput and sensitivity for peptide hormones and steroid analytes. Radioimmunoassay remains in use for select low-concentration hormones in appropriately licensed facilities.
Chromatographic and Mass Spectrometric Methods
Liquid chromatography–tandem mass spectrometry (LC-MS/MS) provides superior specificity and multiplexing capability, enabling simultaneous quantification of steroid panels such as testosterone, estradiol, 17-hydroxyprogesterone, and aldosterone with minimal cross-reactivity. Gas chromatography–mass spectrometry is applied to specific steroid metabolite profiling and confirmatory workflows.
Dynamic Function Tests
When basal measurements are borderline, dynamic protocols assess glandular reserve and feedback integrity. Common examples include the ACTH stimulation test for adrenal insufficiency, the overnight or low-dose dexamethasone suppression test for hypercortisolism, the oral glucose tolerance test with insulin measurement for insulin resistance, and clonidine or glucagon stimulation testing for growth hormone deficiency. These tests require controlled administration of pharmacological agents and serial timed sampling under medical supervision.
Molecular and Genetic Analysis
Polymerase chain reaction and next-generation sequencing identify germline or somatic mutations associated with inherited endocrine syndromes, such as multiple endocrine neoplasia, congenital adrenal hyperplasia, and familial medullary thyroid carcinoma, complementing biochemical findings with etiological confirmation.
Applications
Endocrine function assessment supports a broad range of clinical, occupational, and research applications:
- Clinical diagnosis and monitoring of thyroid disease, diabetes mellitus, polycystic ovary syndrome, adrenal insufficiency, Cushing syndrome, hyperaldosteronism, infertility, and growth disorders
- Pre-employment, occupational health, and wellness screening programs that include thyroid and metabolic hormone evaluation
- Pharmaceutical research and drug safety studies, where hormone endpoints are measured as part of endocrine pharmacology and safety pharmacology protocols in accordance with internationally recognized laboratory practices
- Environmental and public health studies evaluating exposure to endocrine-disrupting chemicals through biomonitoring of hormone and metabolite markers
- Sports science and anti-doping support through detection of exogenous hormone use and profiling of the steroid passport
- Pediatric newborn screening and developmental follow-up for congenital endocrine disorders
FAQ
How should I prepare for endocrine hormone testing?
Most panels require an overnight fast and morning collection between 7 a.m. and 9 a.m. to capture peak hormone levels. Patients should disclose all medications, supplements, and oral contraceptive use, as biotin, glucocorticoids, dopamine agonists, and estrogen therapy can substantially interfere with results. Cycle-dependent hormones in women may require collection on a specified menstrual cycle day.
What is the difference between basal and dynamic endocrine testing?
Basal testing measures resting hormone concentrations in a single sample and is suitable for screening and routine monitoring. Dynamic testing uses controlled stimulation or suppression of an axis with serial sampling to reveal glandular reserve or feedback failure, and is typically reserved for confirming borderline or discordant basal results.
Why are mass spectrometry methods increasingly preferred for steroid hormones?
LC-MS/MS offers higher analytical specificity than immunoassay, reduces cross-reactivity from structurally similar compounds, and allows multiple steroids to be quantified in one run, which improves diagnostic confidence at the low concentrations typical of pediatric and female samples.
How are quality and reliability ensured?
Testing performed in ISO 15189-accredited medical laboratories or ISO/IEC 17025-accredited third-party laboratories follows documented method validation, internal quality control, proficiency testing participation, traceable calibration, and rigorous pre-analytical handling procedures to guarantee reproducible, clinically actionable results.
How long does it take to receive results?
Routine immunoassay panels are generally reported within one to three working days. LC-MS/MS panels, antibody tests, dynamic protocols, and genetic analyses may require five to ten working days depending on batch scheduling and the complexity of interpretation.
